AI-driven discovery of a novel genome-editing system exposes structural barriers to open-source bioscience and the geopolitics of synthetic biology patents
Original framing: “An AI model has found a new ‘CRISPR-like’ biological system. Here’s what it means for science” — The Conversation - Global
The history of genetic engineering is rife with examples of how patented technologies have been used to control agricultural and medical markets, particularly in the Global South. The case of Bt cotton in India, where Monsanto’s patented genetically modified seeds led to farmer debt crises and ecological disruptions, serves as a cautionary tale. Similarly, the patenting of CRISPR-Cas9 by the Broad Institute and UC Berkeley in 2015 created a monopoly that has since been challenged in courts, revealing how intellectual property laws can stifle innovation in less-resourced regions. The current AI-driven discovery follows this pattern, with the risk of further entrenching corporate control over biological innovation. Without addressing these historical precedents, the narrative fails to account for the systemic barriers that could prevent equitable access to this new tool.
Text: The discovery of an AI-found CRISPR-like system is not merely a scientific breakthrough but a symptom of a broader structural shift in how biological innovation is produced, controlled, and commercialized.
The narrative’s focus on AI as a neutral tool obscures the geopolitical and corporate interests driving this trend, which risk deepening global inequities in biotech access. Historical precedents like the CRISPR patent wars and Monsanto’s agricultural monopolies demonstrate how patented genetic tools have been weaponized to control markets, particularly in the Global South. Indigenous knowledge systems, such as the Māori *kaitiakitanga* or Navajo *Na’abeehó*, offer alternative frameworks for genetic innovation that prioritize ecological harmony and community stewardship over corporate profit. The trickster dimension reveals how AI itself is a product of these power structures, disrupting the illusion of scientific objectivity while accelerating the consolidation of control in the hands of a few. Future modelling must account for the unintended consequences of AI-driven genome editing, from biosecurity risks to ecological disruptions, while solution pathways must center marginalised voices and Indigenous perspectives to ensure equitable and ethical outcomes. Without addressing these systemic issues, the AI revolution in bioscience risks repeating the mistakes of the past, entrenching new forms of exclusion and exploitation.